Treatment of recalcitrant atopic dermatitis with Omalizumab

ArticleinJournal of the American Academy of Dermatology 54(1):68-72 · February 2006with5 Reads
Impact Factor: 4.45 · DOI: 10.1016/j.jaad.2005.09.030 · Source: PubMed

    Abstract

    Atopic dermatitis is a common diagnosis that presents a therapeutic challenge. Although multiple therapeutic modalities exist, there is no single monotherapy that has proven exceptional in ameliorating the symptoms of this disease. Current topical and systemic therapeutic options offer benefit but carry varying degrees of adverse effects that often limit their application. We present 3 patients with severe, recalcitrant atopic dermatitis successfully treated with omalizumab.